Dr. Ludwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2009 - 2012
Loyola University Chicago Stritch School of MedicineClass of 2009
Certifications & Licensure
TX State Medical License 2011 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients With Relapsed or Refractory ALL or LL
Roles: Sponsor-Investigator, Contact
- Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Early therapy with sirolimus reduces size of a large solid renal mass but not seizure activity in an infant with tuberous sclerosis.Salar Bani Hani, Maddy Artunduaga, Kathleen Ludwig, John J Bissler, Matthias T F Wolf
Journal of Nephrology. 2024-01-01 - 1 citationsGenomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.Ruifang Zheng, Franklin Fuda, Jeffrey R Gagan, Olga K Weinberg, Prasad Koduru
Leukemia Research Reports. 2024-01-01 - 57 citationsRecent progress in the treatment of cancer in childrenErin Butler, Kathleen Ludwig, Holly L Pacenta, Laura J. Klesse, Tanya C. Watt
CA. 2021-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
